In fact, conditioned media from CRC cells with acquired or conferred KRAS/BRAF mutations induced greater EGFR/ERK phosphorylation in the presence of cetuximab in WT CRC cells compared to conditioned media from parental cells [82]. Here, KRAS is linked to colorectal carcinoma.